30 Cases of AstraZeneca Vaccine 'Blood Clot Side Effects' Reported in the UK

30 Cases of Rare Thrombosis Reported After 18.1 Million Vaccine Doses Administered

AstraZeneca's novel coronavirus vaccine. Photo by AP/ Yonhap News

[Asia Economy Reporter Kim Heeyoon] It has been reported that 25 additional cases of blood clots occurred after AstraZeneca vaccine administration in the United Kingdom.

On the 1st (local time), according to major foreign media, the UK Medicines and Healthcare products Regulatory Agency (MHRA) announced that 30 rare blood clot cases were reported after 18.1 million doses of the AstraZeneca vaccine were administered.

In particular, MHRA added that 25 of these cases were reported on the day of the announcement. Additionally, it was noted that no blood clot cases were reported after Pfizer vaccine administration.

Previously, MHRA announced that 5 blood clot cases occurred after 11 million doses were administered last month.

With this case report, the existing view that blood clot occurrences are a unique case only on the European continent has been denied, raising concerns about the AZ vaccine.

Norway and Denmark have already suspended AZ vaccine administration. France, Sweden, Finland, Canada, Germany, and others do not recommend AZ vaccine administration for young people.

Meanwhile, MHRA emphasized that although additional blood clot cases have been reported, preventing COVID-19 through vaccination is still considered far more beneficial than the risk of blood clots.

This content was produced with the assistance of AI translation services.